Market Tracker

08/03 6:39pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

2.14
Delayed Data
As of 2:19pm ET
 -0.05 / -2.28%
Today’s Change
1.95
Today|||52-Week Range
9.30
-68.70%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close2.19
Today’s open2.17
Day’s range2.14 - 2.22
Volume17,700
Average volume (3 months)179,646
Market cap$85.1M
Dividend yield--
Data as of 2:19pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-52.28%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc-0.07-3.93%
CGIXCancer Genetics Inc-0.67-6.28%
GALTGalectin Therapeutic...+0.19+7.39%
GBSNUGreat Basin Scientif...-0.22-1.35%
Data as of 3:06pm ET, 08/03/2015

Financials

Next reporting dateSeptember 28, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts